This grant, offered by the Department of Defense’s Lung Cancer Research Program, is for clinical fellows seeking to establish a career in lung cancer research. It provides funding to support a research project conducted under the guidance of an experienced mentor, ensuring at least 40% of the fellow’s time is dedicated to research. The award aims to prepare fellows with clinical duties for a research-focused career, encouraging strong commitment to lung cancer research and clinical practice. Applications must address specific areas of emphasis, including the identification and development of non-invasive tools for early detection and screening, understanding molecular mechanisms, innovative prevention and treatment strategies, identifying predictive/prognostic markers, and understanding acquired treatment resistance.
Opportunity ID: 48866
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | W81XWH-09-LCRP-CFRA |
Funding Opportunity Title: | FY09 DOD Lung Cancer Clinical Fellow Research Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 3 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 3 |
Posted Date: | Aug 03, 2009 |
Last Updated Date: | Aug 28, 2009 |
Original Closing Date for Applications: | Dec 03, 2009 |
Current Closing Date for Applications: | Dec 03, 2009 |
Archive Date: | Jan 02, 2010 |
Estimated Total Program Funding: | $650,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: | The LCRP Clinical Fellow Research Award (CFRA) supports a research project performed by a clinical fellow under the guidance of a designated mentor having an established lung cancer research program. This award is intended to prepare fellows with clinical duties and/or responsibilities for a career in lung cancer research. The Principal Investigator (PI) must be in either an accredited medical residency or medical fellowship program. The DOD LCRP strongly encourages submissions from, and partnerships with, investigators at Military Treatment Facilities, Military Research Institutions, and the Department of Veterans Affairs (VA) Medical Centers and research laboratories.Funds from this award are intended to provide aggressive protection, of at least 40%, of the clinical fellows time for research. The clinical fellow must demonstrate a strong commitment to a career in lung cancer research and clinical practice.Areas of Emphasis: The FY09 LCRP CFRA ONLY accepts applications that address at least one of the seven Areas of Emphasis listed below: Identification or development of non-invasive or minimally invasive tools to improve the detection of the initial stages of lung cancer Identification and development of tools for screening or early detection of lung cancer. Screening may include, but is not limited to, computed tomography scans, X-rays, other imaging, biomarkers, genetics/genomics/proteomics, and assessment of risk factors Understanding the molecular mechanisms that lead to clinically significant lung cancer Identification of the mechanisms that lead to the development of the various types of lung cancer Identification of innovative strategies for prevention and treatment of early lung cancer Understanding predictive and prognostic markers to identify responders and non-responders Understanding acquired resistance to treatmentSee the Program Announcement for the full Funding Opportunity Description. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
Version History
Version | Modification Description | Updated Date |
---|---|---|
The purpose of this modification is to revise: (1) the Program Announcement document, (2) the Application Instructions & General Information document, and (3) the Application Form Package. The revised Application Form Package included in this modification must be used in completing the application. Failure to use this Application Form Package may result in the rejection of the application when submitted in Grants.gov. | Aug 28, 2009 | |
The purpose of this modification is to revise: (1) the Program Announcement document, (2) the Application Instructions & General Information document, and (3) the Application Form Package. The revised Application Form Package included in this modification must be used in completing the application. Failure to use this Application Form Package may result in the rejection of the application when submitted in Grants.gov. | Aug 28, 2009 | |
Aug 28, 2009 |
DISPLAYING: Synopsis 3
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | W81XWH-09-LCRP-CFRA |
Funding Opportunity Title: | FY09 DOD Lung Cancer Clinical Fellow Research Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 3 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 3 |
Posted Date: | Aug 03, 2009 |
Last Updated Date: | Aug 28, 2009 |
Original Closing Date for Applications: | Dec 03, 2009 |
Current Closing Date for Applications: | Dec 03, 2009 |
Archive Date: | Jan 02, 2010 |
Estimated Total Program Funding: | $650,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: | The LCRP Clinical Fellow Research Award (CFRA) supports a research project performed by a clinical fellow under the guidance of a designated mentor having an established lung cancer research program. This award is intended to prepare fellows with clinical duties and/or responsibilities for a career in lung cancer research. The Principal Investigator (PI) must be in either an accredited medical residency or medical fellowship program. The DOD LCRP strongly encourages submissions from, and partnerships with, investigators at Military Treatment Facilities, Military Research Institutions, and the Department of Veterans Affairs (VA) Medical Centers and research laboratories.Funds from this award are intended to provide aggressive protection, of at least 40%, of the clinical fellows time for research. The clinical fellow must demonstrate a strong commitment to a career in lung cancer research and clinical practice.Areas of Emphasis: The FY09 LCRP CFRA ONLY accepts applications that address at least one of the seven Areas of Emphasis listed below: Identification or development of non-invasive or minimally invasive tools to improve the detection of the initial stages of lung cancer Identification and development of tools for screening or early detection of lung cancer. Screening may include, but is not limited to, computed tomography scans, X-rays, other imaging, biomarkers, genetics/genomics/proteomics, and assessment of risk factors Understanding the molecular mechanisms that lead to clinically significant lung cancer Identification of the mechanisms that lead to the development of the various types of lung cancer Identification of innovative strategies for prevention and treatment of early lung cancer Understanding predictive and prognostic markers to identify responders and non-responders Understanding acquired resistance to treatmentSee the Program Announcement for the full Funding Opportunity Description. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
DISPLAYING: Synopsis 2
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | W81XWH-09-LCRP-CFRA |
Funding Opportunity Title: | FY09 DOD Lung Cancer Clinical Fellow Research Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 3 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 2 |
Posted Date: | Aug 28, 2009 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Dec 03, 2009 |
Archive Date: | Jan 02, 2010 |
Estimated Total Program Funding: | $650,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: | The LCRP Clinical Fellow Research Award (CFRA) supports a research project performed by a clinical fellow under the guidance of a designated mentor having an established lung cancer research program. This award is intended to prepare fellows with clinical duties and/or responsibilities for a career in lung cancer research. The Principal Investigator (PI) must be in either an accredited medical residency or medical fellowship program. The DOD LCRP strongly encourages submissions from, and partnerships with, investigators at Military Treatment Facilities, Military Research Institutions, and the Department of Veterans Affairs (VA) Medical Centers and research laboratories.Funds from this award are intended to provide aggressive protection, of at least 40%, of the clinical fellows time for research. The clinical fellow must demonstrate a strong commitment to a career in lung cancer research and clinical practice.Areas of Emphasis: The FY09 LCRP CFRA ONLY accepts applications that address at least one of the seven Areas of Emphasis listed below: Identification or development of non-invasive or minimally invasive tools to improve the detection of the initial stages of lung cancer Identification and development of tools for screening or early detection of lung cancer. Screening may include, but is not limited to, computed tomography scans, X-rays, other imaging, biomarkers, genetics/genomics/proteomics, and assessment of risk factors Understanding the molecular mechanisms that lead to clinically significant lung cancer Identification of the mechanisms that lead to the development of the various types of lung cancer Identification of innovative strategies for prevention and treatment of early lung cancer Understanding predictive and prognostic markers to identify responders and non-responders Understanding acquired resistance to treatmentSee the Program Announcement for the full Funding Opportunity Description. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
DISPLAYING: Synopsis 1
General Information
Document Type: | Grants Notice |
Funding Opportunity Number: | W81XWH-09-LCRP-CFRA |
Funding Opportunity Title: | FY09 DOD Lung Cancer Clinical Fellow Research Award |
Opportunity Category: | Discretionary |
Opportunity Category Explanation: | – |
Funding Instrument Type: | Cooperative Agreement Grant |
Category of Funding Activity: | Science and Technology and other Research and Development |
Category Explanation: | – |
Expected Number of Awards: | 3 |
Assistance Listings: | 12.420 — Military Medical Research and Development |
Cost Sharing or Matching Requirement: | No |
Version: | Synopsis 1 |
Posted Date: | Aug 28, 2009 |
Last Updated Date: | – |
Original Closing Date for Applications: | – |
Current Closing Date for Applications: | Dec 03, 2009 |
Archive Date: | Jan 02, 2010 |
Estimated Total Program Funding: | $650,000 |
Award Ceiling: | – |
Award Floor: | – |
Eligibility
Eligible Applicants: | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” |
Additional Information on Eligibility: | – |
Additional Information
Agency Name: | Dept. of the Army — USAMRAA |
Description: | The LCRP Clinical Fellow Research Award (CFRA) supports a research project performed by a clinical fellow under the guidance of a designated mentor having an established lung cancer research program. This award is intended to prepare fellows with clinical duties and/or responsibilities for a career in lung cancer research. The Principal Investigator (PI) must be in either an accredited medical residency or medical fellowship program. The DOD LCRP strongly encourages submissions from, and partnerships with, investigators at Military Treatment Facilities, Military Research Institutions, and the Department of Veterans Affairs (VA) Medical Centers and research laboratories. Funds from this award are intended to provide aggressive protection, of at least 40%, of the clinical fellows time for research. The clinical fellow must demonstrate a strong commitment to a career in lung cancer research and clinical practice. Areas of Emphasis: The FY09 LCRP CFRA ONLY accepts applications that address at least one of the seven Areas of Emphasis listed below: Identification or development of non-invasive or minimally invasive tools to improve the detection of the initial stages of lung cancer Identification and development of tools for screening or early detection of lung cancer. Screening may include, but is not limited to, computed tomography scans, X-rays, other imaging, biomarkers, genetics/genomics/proteomics, and assessment of risk factors Understanding the molecular mechanisms that lead to clinically significant lung cancer Identification of the mechanisms that lead to the development of the various types of lung cancer Identification of innovative strategies for prevention and treatment of early lung cancer Understanding predictive and prognostic markers to identify responders and non-responders Understanding acquired resistance to treatment See the Program Announcement for the full Funding Opportunity Description. |
Link to Additional Information: | – |
Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil
eReceipt HELP: 301-682-5507; help@cdmrp.org Email:cdmrp.pa@amedd.army.mil |
Related Documents
Folder 48866 Full Announcement-1 -> biosketchjune09.pdf
Folder 48866 Full Announcement-1 -> lcrp fy09 cfra pa edited_post saab-7.30.09 final.pdf
Folder 48866 Full Announcement-1 -> budget form reader.pdf
Packages
Agency Contact Information: | PA HELP: 301-619-7079; cdmrp.pa@amedd.army.mil eReceipt HELP: 301-682-5507; help@cdmrp.org Email: cdmrp.pa@amedd.army.mil |
Who Can Apply: | Organization Applicants |
Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
---|---|---|---|---|---|---|
12.420 | PKG00013415 | Aug 03, 2009 | Dec 03, 2009 | View |
Package 1
Mandatory forms
48866 RR_SF424-1.1.pdf
48866 RR_PerformanceSite-1.1.pdf
48866 RR_KeyPersonExpanded-1.1.pdf